The Return of a Forgotten Killer: Why Diphtheria’s Comeback Should Alarm Us All
It’s easy to forget the horrors of diseases we’ve nearly eradicated. Diphtheria, once a leading cause of childhood death, has reemerged in Australia, and it’s a stark reminder of how fragile our progress can be. Personally, I think this resurgence is more than just a public health issue—it’s a wake-up call about the consequences of complacency.
A Disease We Thought Was Behind Us
Diphtheria was a terror in the early 20th century, killing thousands in Australia alone. Vaccination campaigns in the 1930s turned the tide, and by the 1950s, it was all but forgotten. But here’s the thing: diseases don’t disappear; they wait. What makes this particularly fascinating is how quickly a decline in vaccination rates can bring them back. Recent outbreaks in the Northern Territory, Western Australia, and Queensland are a chilling example.
The Perfect Storm of Vaccine Hesitancy and Practical Barriers
One thing that immediately stands out is the drop in childhood vaccination rates since the COVID-19 pandemic. In 2025, coverage among Australian toddlers fell to its lowest in five years. This isn’t just about anti-vaxxers—though they play a role. Practical barriers like access to healthcare and the cost of appointments are equally to blame. What many people don’t realize is that even small gaps in immunity create pockets of vulnerability, allowing diseases like diphtheria to spread.
Why Diphtheria’s Return Matters
Diphtheria isn’t just a relic of the past; it’s a brutal disease. Respiratory diphtheria can suffocate you by coating your throat in a grayish membrane, while cutaneous diphtheria leaves chronic, infectious sores. Even with treatment, up to 10% of respiratory cases are fatal. What this really suggests is that our modern healthcare systems, despite their advancements, are still no match for preventable diseases when vaccination rates slip.
The Hidden Challenges of Treatment
Here’s a detail that I find especially interesting: the diphtheria antitoxin, crucial for treating severe cases, is in short supply globally. Its production has declined due to the disease’s rarity—until now. This raises a deeper question: how prepared are we for the return of diseases we thought we’d conquered? Relying solely on antibiotics isn’t enough, especially when the toxin can cause irreversible damage to the heart and nerves.
The Role of Inequality in Outbreaks
If you take a step back and think about it, diphtheria’s resurgence isn’t evenly distributed. Aboriginal and Torres Strait Islander children in the NT, for instance, have higher vaccination rates than the general population. This highlights a broader issue: health disparities often drive disease outbreaks. In my opinion, addressing these inequalities is just as critical as promoting vaccines themselves.
What’s Next?
Reversing this trend requires more than just public health campaigns. We need to tackle the systemic issues—like access to healthcare and trust in medical providers—that contribute to declining vaccination rates. From my perspective, investing in primary care and fostering empathetic, informed conversations about vaccines are key.
Final Thoughts
Diphtheria’s comeback is a reminder that progress isn’t permanent. It’s also a call to action. Whether you’re a parent, a healthcare worker, or just someone who cares about public health, this is a moment to reflect. Are we doing enough to protect future generations? Personally, I think the answer is no—but it’s not too late to change course.
